Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
peginterferon alfa-2a interferon-alpha 2 NA Successful target TTD , DGIDB Hepatitis B[MeSHID:D006509]
Liver diseases[MeSHID:D008107]
Virus Replication[MeSHID:D014779]
Hepatitis[MeSHID:D006505]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hairy Cell Leukemia[MeSHID:D007943]
NA approved unknown
peginterferon alfa-2a interferon alpha/beta receptor 1 biotech NA drugbank , DGIDB Hepatitis B[MeSHID:D006509]
Liver diseases[MeSHID:D008107]
Virus Replication[MeSHID:D014779]
Hepatitis[MeSHID:D006505]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hairy Cell Leukemia[MeSHID:D007943]
2.65 approved,investigational agonist
peginterferon alfa-2a interferon alpha/beta receptor 1 biotech NA drugbank , DGIDB Hepatitis B[MeSHID:D006509]
Liver diseases[MeSHID:D008107]
Virus Replication[MeSHID:D014779]
Hepatitis[MeSHID:D006505]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hairy Cell Leukemia[MeSHID:D007943]
NA approved,investigational agonist
peginterferon alfa-2a interferon alpha/beta receptor 2 biotech NA drugbank , DGIDB Hepatitis B[MeSHID:D006509]
Liver diseases[MeSHID:D008107]
Virus Replication[MeSHID:D014779]
Hepatitis[MeSHID:D006505]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Hairy Cell Leukemia[MeSHID:D007943]
2.65 approved,investigational agonist
click here to return to the previous page